By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Atlas Bio leaves stealth with $12.5M to test drugs on simulated patients
    By
    msadmin
    October 27, 2026
    Practo’s founder banks $15M to screen healthy Indians for hidden disease
    By
    msadmin
    October 27, 2026
    Heartflow hauls a second rival into court over cardiac CT software
    By
    msadmin
    October 27, 2026
    Coreline Soft adds aortic measurements to its chest CT platform
    By
    msadmin
    October 27, 2026
    A self-taught model rebuilds blood flow maps from paediatric heart scans
    By
    msadmin
    October 27, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Brain implant decoders fail when patients or hardware change, review warns
    By
    msadmin
    October 25, 2026
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
    Consumer chatbots are building a medical system outside hospitals
    By
    msadmin
    August 21, 2026
    Reasoning gaps hold back AI agents in scientific discovery
    By
    msadmin
    August 11, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

Inspiren lands $70M as senior living operators adopt room sensors

The company's sensors and AI watch for falls and changing conditions inside senior living apartments.

MedSpark Staff
By
msadmin
MedSpark Staff
Bymsadmin
Medical, Healthcare, & Biotech/Pharma AI News
Follow:
Published: September 12, 2026
Share
2 Min Read
SHARE

Inspiren raised $70M in a round led by NewView Capital. The investor group also included Insight Partners, Primary Venture Partners, Scale Venture Partners, Vintage Investment Partners, Lightbank, Avenir Growth Capital, Story Ventures and Camber Creek.

The deal values the company above $500M and lifts total funding to $225M. Inspiren sells sensors and AI that watch over residents in senior living communities.

The goal is catching needs that would otherwise go unnoticed. Michael Wang, the founder and chief clinical officer, predicted that in a decade nobody will accept a resident’s needs going unnoticed behind a closed door.

Its reach covers 80% of the largest senior housing investors, among them AEW and Sabra Healthcare REIT. Operators using it include Arrow Senior Living, Ascent Living Communities, Heritage Communities, Thrive Senior Living and Wellpointe.

Wang said the money will widen what its models detect, predict and act on across a community. Deeper integrations with the leading electronic health record platforms are part of the plan too. He described an aggressive roadmap spanning hardware and software with no fixed deployment timeline.

Senior living operators run on thin staffing margins while resident acuity climbs. That combination makes continuous monitoring one of the few technology categories with a direct labor story.

TAGGED:Aging CareAmbient MonitoringEHR IntegrationfundingHealth SensorsInspirenSenior Living
SOURCES:Senior Housing News
Share This Article
Facebook Copy Link Print
MedSpark Staff
Bymsadmin
Follow:
Medical, Healthcare, & Biotech/Pharma AI News

You Might Also Like

News & Alerts

A first patient receives Generate’s AI-designed cell therapy for ovarian cancer

By
msadmin
October 1, 2026
Lunit pushes its pathology AI into drug trials through a US lab deal
News & Alerts

Lunit takes pathology AI into drug research with US lab pact

By
msadmin
October 12, 2026
ArticlesNews & Alerts

AI-powered biosimulation shakes up animal drug testing

By
msadmin
July 17, 2026
News & Alerts

Omniscient clears FDA to map DBS leads with connectomics

By
msadmin
September 13, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal